Riskpilot← Back to searchSign inGet full accessAVALDSNES LEGESENTER AS
ASActiveOrg 914815452Allmenn legetjeneste · NACE 86211Est. 20150 employeesavaldsneslegesenter.no
Revenue 2022
NOK 2,5M
-12% vs 2021
EBITDA margin
2.1%
+128% vs 2021
Equity ratio
49.5%
Financial strength
Net profit 2022
NOK 44K
+123% vs 2021
| Revenue | NOK 2,5M | -12% |
| EBITDA | NOK 51K | +128% |
| Net profit | NOK 44K | +123% |
| Total assets | NOK 236K | +310% |
| Equity | NOK 117K | +119% |
| Employees | 0 | — |
Legal name
AVALDSNES LEGESENTER AS
Org number
914815452
Legal form
Aksjeselskap
NACE code
86211 · Allmenn legetjeneste
Founded
16. januar 2015
Share capital
NOK 3 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utføre laboratorietjenester og administrasjonstjenester, herunder bl.a. Legesekretærfunksjoner og sentralbordtjeneste, for tilknyttet legevirksomhet, og alt hva hermed står i forbindelse.
Address
Phone
+4752845370
Email
post@avaldsneslegesenter.no
Website
avaldsneslegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 2 601 | 2 794 | 2 847 | 2 811 | 2 467 |
| Staff expenses | −1 378 | −1 338 | −1 380 | −1 351 | −1 173 |
| EBITDA | −78 | −9 | 9 | −182 | 51 |
| Depreciation & amort. | −0 | −3 | −4 | −4 | −4 |
| EBIT | −78 | −13 | 5 | −186 | 47 |
| Net financials | −2 | −3 | −2 | −1 | −3 |
| Profit before tax | −80 | −16 | 3 | −187 | 44 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −80 | −16 | 3 | −187 | 44 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 18 | 103 | −64 | −112 | 236 |
| Equity | −401 | −417 | −413 | −600 | 117 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 419 | 520 | 349 | 488 | 119 |
| Total debt | 419 | 520 | 349 | 488 | 119 |
EBITDA margin
2.1%
This company
15.8%
Market median
-87% vs market
20182022
Equity ratio
49.5%
This company
38.2%
Market median
+30% vs market
20182022
Return on equity
37.5%
This company
18.4%
Market median
+104% vs market
20182022
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20182022
Asset turnover
10.46×
This company
1.12×
Market median
+834% vs market
20182022
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2017 | |
| Chairman | 2017 | |
| Former (1) | ||
| Board of Directors | 2017 – 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AVALDSNES LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Beate Langhelle | Board of Directors | 0 companies |
| Mohammed Miran Miah | Board of Directors | 0 companies |
| Kari Nesse | Chairman | 0 companies |